Manuka honey is a monofloral honey produced from the nectar of the Leptospermum scoparium bush, native to New Zealand, and has been studied for a notably wide range of potential health applications. Research suggests that its unique compound methylglyoxal (MGO) contributes to antimicrobial properties that distinguish it from conventional honeys, with studies indicating promising effects in wound healing, supporting digestive health, and soothing sore throats. Some research has also explored its potential role in supporting immune function and promoting skin health when applied topically. Manuka honey is commonly graded using the UMF (Unique Manuka Factor) rating system, which reflects the concentration of key bioactive compounds. While traditional use spans centuries in indigenous Maori medicine, modern scientific investigation continues to clarify the scope and mechanisms of its functional benefits.
Compare this supplementResearch suggests that Manuka honey possesses meaningful antimicrobial properties, with studies consistently identify...
View studies →Research suggests that Manuka honey has meaningful wound-healing properties supported by a convergence of laboratory,...
View studies →The single study identified in connection with this topic does not directly investigate Manuka honey or digestive hea...
View studies →Research on Manuka honey specifically for immune function is extremely limited in the available evidence base, with o...
View studies →The available linked study does not contain research relevant to Manuka honey or skin health. The single study provid...
View studies →Research suggests that the direct evidence for Manuka honey specifically as a sore throat remedy is not represented i...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Liquid | 10 g | Three times daily | antimicrobial support and immune function | Common dosing pattern in pilot trials examining systemic antimicrobial activity |
| Liquid | 20–30 g | Daily | digestive health and H. pylori suppression | Doses used in small clinical trials examining gastrointestinal effects |
| Liquid | 10–20 g | Daily | sore throat relief and upper respiratory support | Used in clinical studies on cough and throat irritation, typically 1–2 teaspoons |
| Topical | — | As needed | wound healing and skin health; applied directly to wound or skin area | Applied as a dressing in clinical wound care studies; quantity varies by wound size |